The big health industry trillion market calls out, hundreds of pharmaceutical companies to participate in it

In recent years, with the improvement of people's living standards in China, the demand for health services is shifting from traditional disease treatment to disease prevention and health care.
, China's large health industry has entered a golden period of development.
with the national "13th Five-Year Plan" and "Healthy China 2030" planning outline has landed, the large health industry has shown a booming trend, trillion market calls out.
trillion market for the big health industries, hundreds of pharmaceutical companies are involved (Photo: Pharmaceutical Network) According to estimates by the China Institute of Science and Technology Development Strategy, the potential of the entire health industry will reach 10 trillion yuan by 2020.
will exceed 16 trillion yuan by 2030, three times the current market size.
aimed at this market blue sea, hundreds of pharmaceutical companies "without appointment" to participate in the layout of health food, day-to-day and other large health areas.
from the specific actions of pharmaceutical companies, Shi Pharmaceutical Group, Hua Pharmaceuticals, Kun Pharmaceutical Group, Panlong Yunhai, Taiji Group, Tianshili and other traditional pharmaceutical companies set up a special large health division.
this year, there are also pharmaceutical companies in the field of quasi-large health has set up a new large health division.
, for example, in March, Connbey announced that the company's ninth board of directors would hold its second interim meeting in 2020 to consider the adoption of the Bill on the Establishment of the Company's Big Health Division.
in accordance with the company's further development of modern Chinese medicine, plant medicine-based large health business strategy, seize the opportunity to better plan, layout, development and management of large health products business, agreed to set up the company's large health business unit.
addition to the establishment of a large health division, the revision of the pharmaceutical industry is a full-side layout of the industrial chain.
It is learned that the revision of the pharmaceutical industry in the big health industry has been laid out for many years, relatively rich products, basically meet all aspects of people's food and clothing, including biscuits, beverages, baby supplies, toothpaste, tea, mask, mineral water, health wine, etc., launched a variety of "big health products."
many traditional Chinese medicine enterprises have also opened up a new wave of health care, the concept of Chinese medicine health care into the modern elements, so that Chinese medicine younger, fashionable, life.
, Tongrentang has created a new brand IP know well health, committed to the new idea of national tide health.
now knows that Health has two stores in Beijing, namely, No. 0 store in Daxing District and No. 1 store in Shuangjing.
, zero shop across the elephant, food, health, medicine four products and services.
store has two floors, one layer will be diet and life fusion, including precision food therapy, health tea, coffee, etc. , the second floor is the traditional Chinese pharmacy, as well as the old Chinese medicine doctor.
with the rise of the big health industry, health care is gradually becoming the focus of public concern, but also the focus of investors.
the combination of rising prevalence of chronic diseases, increasing aging and rising consumption levels, the pension market will grow rapidly or spark a market battle.
, the layout of related enterprises in the big health industry in the area of old-age care has also attracted much attention.
June, ST Dong ocean in the interactive platform to respond to investors said that according to the company's large health industry development strategic plan, the company's large health business division has now laid out four major technology platforms, including immune technology platform, mass spectrometry technology platform, molecular technology platform and third-party medical testing laboratory.
in the industry, in recent years, with the increasing cost and industrial concentration of pharmaceutical companies, market competition is becoming increasingly fierce.
with the gradual improvement of the new medical reform policy, drug price reduction under the collection has become a major trend, forcing pharmaceutical companies to innovate research and development, or broaden the product line.
health industry has broad prospects, pharmaceutical companies to enter the field, or access to development opportunities.
But the broad range of emerging large health industries, including nutritional health food, healthcare equipment, leisure health services, etc., believes that if companies can break the single product model, but provide healthy living solutions, or can create greater business opportunities.